There’s something buzzing in the pharmaceutical industry’s pot, and it’s not just the caffeine in our favorite bodega brew. On the crispy morning of December 3, 2024, Bristol Myers Squibb, a heavyweight in the drug-discovering arena, decided to dance with a young, dashing startup, AI Proteins, in what may feel like a cacophony of test […]
Oh, Warren Buffett, the Oracle of Omaha. His company, Berkshire Hathaway, is sitting on a cool $325 billion in cash. That’s a lot of zeroes, folks. This slick move came after he decided to part ways with some of his steadfast investments in Apple and Bank of America shares. Why the big sale? Let’s dig […]
